It will not be easy, but Mr Erdogan seems determined to plough on.
As the colliery begins to wind down in phases in the new year some workers will continue to plough on.
The IASB will probably plough on and hope the commission backs down.
Main road priority licenses main road traffic to plough on regardless of who was there first, including side road traffic and people on foot waiting to cross.
But the government is likely to plough on, he says, because the prospect of bankruptcy and a potential exit from the eurozone strikes fear into the hearts of its leaders.
Better, surely, to plough on with trying to rebalance the economy away from its dependence on a boom-bust consumer-spending cycle and towards investment and exports (however long and arduous that economic reconstruction may turn out to be).
But the Lords (starting at 11am) plough remorselessly on with the committee stage of the Health and Social Care Bill - day six, and from 2pm they will be considering the Welfare Reform Bill in grand committee.
BBC: Viewing guide: The pick of the week ahead in Parliament
Schering-Plough is working on the control problems with the FDA and should have them resolved shortly.
Now Schering-Plough is working on what could be a new cardiovascular hit.
Schering-Plough continues to execute on our Action Agenda and is now building the base and diversifying and strengthening the company, particularly through the recent acquisition of Organon BioSciences.
During the 1980s and '90s, Schering-Plough refined its focus on four key therapeutic areas and integrating new technologies to achieve important pharmaceutical advances in antihistamines, corticosteroids, antibiotics, anti-infectives and antiviral products.
Steffan James Bowdley, aged 31, was killed after he was struck on the A525 in Llandegla, Denbighshire, near The Plough pub at about 23:00 GMT on Wednesday.
The current gold standard of treatment is Schering-Plough's Rebetron, on the market for three years.
For Merck and Schering-Plough, the pile-on over the cholesterol drug Vytorin shows no signs of letting up.
Their grandfather probably exploited the great fertility that is American soil, dropped his plough, and then moved on to the Midwest and exploited it all over again.
This morning, on Schering-Plough's first-quarter earnings conference call, Schering Chief Executive Fred Hassan reminded the drug industry why it fell in love with him in the first place.
Richard Smith , an editor at the British Medical Journal (BMJ), writes of a case in which his journal published a study on Schering-Plough 's (nyse: SGP - news - people) drug, flutamide.
The company is betting on studies showing that patients with certain strains of the hepatitis C virus can do with half as much time on Pegasys as they can on Schering-Plough 's (nyse: SGP - news - people ) Peg-Intron.
Ryan rates Schering-Plough a "buy" based on the upside from the drug.
On its purchase of Schering Plough, which does have some new drug opportunities, Merck is shuttering several research centers.
The result is a palpable sense of confidence among Korean companies that they will plough their own distinct furrow focussed not on the past but on crafting a different future.
Schering-Plough faces a U.S. delay on its anesthesia drug sugammadex and declining sales of the cholesterol drugs Zetia and Vytorin, which it sells with Merck.
Moreover, insurance companies have raised the co-pays on prescription antihistamines since Schering-Plough (nyse: SGP - news - people ) began selling its Claritin over the counter.
In a potentially damaging result, a long-delayed study showed Merck and Schering-Plough's expensive Vytorin had no benefit on the buildup of artery plaque over the older drug Zocor, even though Vytorin cut bad cholesterol 40% more.
Vertex's stock sank 13% on Oct. 18 when Schering-Plough touted promising results for its rival protease inhibitor.
Vertex's stock sank 13% on Oct. 18 when Schering-Plough (nyse: SGP - news - people ) touted promising results for its rival protease inhibitor.
"Schering-Plough does not provide numeric guidance and does not comment on the guidance of other companies, " the statement says.
That could be a bigger benefit to beaten-down Schering-Plough than to Merck, which will lose patent protection on Zocor in 2006.
"We pull together panels and seek expert advice on an ongoing basis, " says Schering-Plough spokesman Davies.
Schering-Plough is expected to present new safety data to address this on Tuesday.
应用推荐